Quezada M, Aguilar OG, González AEE, Zapata PD, Macías AE

Language: Spanish
References: 16
Page: 75-80
PDF size: 247.42 Kb.

ABSTRACT

Background. Respiratory syncytial virus (RSV) is an important cause of illness and death, particularly in children under four years of age.
Objective. To determine the frequency of rsv infections and other respiratory pathogens in a regional hospital.
Methods. Descriptive study of respiratory specimens submitted for multiple molecular test (NAAT) from patients with acute respiratory infection in the period from January 1, 2018 to December 31, 2019.
Results. 297 specimens from patients with a median age of 11.2 months were studied, with an interquartile range (IQR) of 3-35 months. RSV predominated, followed by rhinovirus/enterovirus. The coexistence of more than one microorganism in a test was found in some samples; in 65 specimens (21.8%) two microorganisms were found and in four (1.3%) three were found. Bordetella sp. was identified in 12 (4%) specimens. Regarding RSV, the median age in months was 7.5 and IQR 2-22 months. RSV and coronaviruses predominated in winter, rhinoviruses/enteroviruses predominated between autumn and winter.
Discussion. RSV is the pathogen most frequently detected by the naat test in acute conditions, followed by rhinovirus/ enterovirus. Viruses represent the main pathogens of acute respiratory diseases.

REFERENCES

1. Zhou, H., Thompson, W.W., Viboud, C.G., Ringholz, C.M., Cheng, P.Y. et al., “Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008”, Clin Infect Dis, 2012, 54: 1427-1436.

2. Meng, J., Stobart, C.C., Hotard, A.L. y Moore, M.L., “An overview of respiratory syncytial virus”, plos Pathog, 2014, 10 (4): e1004016.

3. Thompson, W.W., Shay, D.K., Weintraub, E., Brammer, L., Cox, N. et al., “Mortality associated with influenza and respiratory syncytial virus in the United States”, jama, 2003, 289: 179-186.

4. Nair, H., Nokes, D.J., Gessner, B.D., Dherani, M. et al., “Globalburden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis”, Lancet, 2012, 375: 1545- 1555.

5. Mahadevia, P.J., Masaquel, A.S., Polak, M.J. y Weiner, L.B., “Cost utility of palivizumab prophylaxis among preterm infants in the United States: a national policy perspective”, J Med Econ, 2012, 15: 987-996.

6. Wong-Chew, R.M., Farfán-Quiroz, R., Sánchez-Huerta, J.L., Nava-Frías, M. et al., “Frecuencia de virus respiratorios y características clínicas de niños que acuden a un hospital en México”, Salud Pública Méx, 2010, 52 (6): 528-532.

7. Obando-Pacheco, P., Justicia-Grande, A.J., Rivero-Calle, I. et al., “Respiratory syncytial virus seasonality: a global overview, JID, 2018, 217 (9): 1356-1364.

8. Ali, A., Lopardo, G., Scarpellini, B., Stein, R. y Ribeiro, D., “Systematic review on respiratory syncytial virus epidemiology in adults and the elderly in Latin America”, International Journal of Infectious Diseases, 2020, 90: 170-180.

9. Lee, W.-M., Lemanske, R., Evans, M. et al., “Human rhinovirus species and season of infection determine illness severity”, Am J Respir Crit Care Med, 2012, 186 (9): 886-891.

10. Price, R.H.M., Graham, C. y Ramalingam, S., “Association between viral seasonality and meteorological factors”, Sci Rep, 2019, 9: 929.

11. Kissler, S., Tedijanto, C., Goldstein, E., Grad, Y. y Lipsitch, M., “Projecting the transmission dynamics of sars-cov-2 through the postpandemic period”, Science, 2020, 368 (6493): 860-868.

12. Saxena, S., Coronavirus disease 2019 (covid-19). Epidemiology, pathogenesis, diagnosis, and therapeutics, 1ª ed., Singapore, Shailendra K. Saxena, 2020.

13. Shi, T., David, A.M., Katherine, L.O. et al., “Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study”, Lancet, 2017, 390: 946-958.

14. Scheltema, N.M., Gentile, A., Lucion, F. et al., “Global respiratory syncytial virus-associated mortality in young children (rsv Gold): a retrospective case series, Lancet Glob Health, 2017, 5 (10): e984-e991. doi:10.1016/S2214- 109X(17)30344-3. [Artículo corregido publicado en Lancet Glob Health, 2017, 5 (12 ): e1190.]

15. Ueno, F., Tamaki, R., Saito, M., Okamoto, M., Saito-Obata, M., Kamigaki, T., Suzuki, A., Segubre-Mercado, E., Aloyon, H.D., Tallo, V., Lupisan, S.P., Oshitani, H. y rsv Working Group in the Philippines”, “Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines”, Influenza and Other Respira- tory Viruses, 2019, 13 (4): 339-353. Disponible en: https:// doi.org/10.1111/irv.12639.

16. Pérez López, Y., González Aguilar, E.E., Aguilar Orozco, G., Lara Lona, E. y Macías, A.E., “Utilidad de las pruebas de un centro privado para determinar la epidemiología local de la influenza”, Enfermedades Infecciosas y Microbiología, 2019, 39 (4): 118-122.